It starts with something that looks like the medicine working. The appetite is gone, the weight is coming off, and the nausea is written off as the price of progress. Then the vomiting does not stop. Then, weeks later, the eyes will not track properly, the walk goes wide and uncertain, and the person who was fine at breakfast cannot say what day it is. Thiamine, vitamin B1, is water soluble, and the body keeps almost none of it in reserve. The American Society for Metabolic and Bariatric Surgery task force that reviewed this literature notes that stores can be emptied in as little as two weeks, sooner in someone whose levels were already low, such as a patient on a restrictive liquid diet before an operation. When they empty, the damage lands in the mammillary bodies and thalamus, and what began as confusion can settle into Korsakoff syndrome, a permanent hole where new memories should form.
The document that says so most plainly is the ASMBS Wernicke's Task Force guideline, published online in Surgery for Obesity and Related Diseases on April 10, 2025, and written by Emma Patterson and nine colleagues. It is not a trial. It is a literature review of human, adult, English-language studies from 2013 onward, including case reports and series, turned into clinical practice recommendations by expert consensus, and the authors say themselves that it is not intended to establish a standard of care. What makes it unusual is a single line in its conclusions: expanding on prior guidelines, the task force recommends "even higher doses of thiamine prior to MBS or starting medical weight loss", on the reasoning that deficiency is already common before an operation and that Wernicke's cases are rising. The guideline reports that up to 29 percent of patients with obesity seeking metabolic and bariatric surgery have been found deficient before surgery, possibly linked to high-carbohydrate, calorie-restricted or liquid diets. Against a recommended daily allowance of 1.2 mg for men and 1.1 mg for women, the maintenance dosing the guideline cites after surgery is a minimum of 12 mg a day and preferably 50 mg once or twice daily.
The structure is the other half of the news. The task force sets thiamine deficiency inside the classic public health frame of primary, secondary and tertiary prevention: keep intake adequate in susceptible people; catch and treat the subclinical stage in patients with poor intake, persistent vomiting, trauma or sepsis before neurological signs appear; and, once Wernicke's is suspected, treat it as the emergency it is with high-dose parenteral thiamine, alongside replacement of magnesium, potassium and phosphorus. The guideline is blunt about what does not work as a safety net. Diagnosis is clinical, made against Caine's criteria; MRI detects only roughly 52 to 65 percent of cases and cannot be used to rule Wernicke's out. It also argues that the traditional 100 mg oral tablet after discharge is likely inadequate for many patients, and recommends higher oral dosing after acute treatment, at 300 mg two or three times daily, with close follow-up. For the surgical population it names concrete triggers for suspicion, including persistent vomiting or weight loss faster than the roughly 8 percent of total body weight expected at three weeks after surgery.
Why this reads differently in 2026 is a paper published in Obesity on July 3, 2026, by Bidesie and colleagues, a PRISMA systematic review of case reports searched to February 10, 2026. It found six published cases of Wernicke's encephalopathy in adults prescribed semaglutide for obesity: four women and two men, mean age 47.2 years, all with prolonged gastrointestinal symptoms and substantial weight loss before the neurological decline, most commonly altered mental status and abnormal eye movements. Outcomes were poor. Four had persistent cognitive deficits consistent with Korsakoff syndrome and one patient died. The reviewers counted an initial parenteral dose below 500 mg as suboptimal treatment, and most patients had received less. Separately, in the European Journal of Clinical Nutrition on September 4, 2025, a French group described one case in a 49-year-old woman and set it beside eighteen others from the literature and VigiBase, the WHO safety database, reporting nausea, vomiting or reduced intake in 68 percent of cases and disproportionate reporting of Wernicke's for semaglutide, tirzepatide and the GLP-1 class overall.
Six cases is six cases. Set against tens of millions of prescriptions, this is a rare event, and none of these reports can tell you how rare, because case reports have no denominator and pharmacovigilance databases record suspicion, not proof. What they can do is describe a shape, and the shape is consistent: months of vomiting and rapid loss, an appetite that never returns, a brain running out of a vitamin nobody thought to check. The reason the ASMBS document matters to a family who has never been near an operating theatre is that its remit was written wide enough to cover them. It is aimed at bariatric patients and at other populations at risk of thiamine deficiency, and it puts people starting medical weight loss inside that circle. As of today it is the published protocol closest to the fastest-growing route into this injury.
None of that is a prescription, and nothing here should be read as one. Doses, routes and durations in this guideline are addressed to clinicians, for patients they have assessed; thiamine levels, other deficiencies and the risk of refeeding all sit in that conversation, not in a newspaper. What a family can reasonably carry into an appointment is the vocabulary: that vomiting which does not settle is not just an inconvenience, that weight coming off faster than expected is a reason to ask about vitamins, and that confusion, double vision or an unsteady walk in someone losing weight quickly is a same-day question, not a next-appointment one. The task force's own comparison is that Wernicke's should be treated with the urgency of a heart attack or a stroke, because the window in which the damage is still reversible is measured in hours and days.